Gain Therapeutics Inc Long-term Investment Intensity
Gain Therapeutics Inc long-term investment intensity. Gain Therapeutics Inc (GANX) has a Long-term Investment Intensity of 4.6% as of March 2023. Long-term investments of $988.39K represent 4.6% of total assets of $21.32 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read GANX current and long-term liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Gain Therapeutics Inc (2022–2022)
Long-term investment intensity of Gain Therapeutics Inc from 2022 to 2022. This chart shows how Gain Therapeutics Inc's Long-term Investment Intensity has evolved across 1 annual periods from 2022 to 2022. As of March 2023, the intensity stands at 4.6%, reflecting long-term investments of $988.39K against total assets of $21.32 Million USD.
Gain Therapeutics Inc Long-term Investment Intensity by Year (2022–2022)
Gain Therapeutics Inc long-term investment intensity by year from 2022 to 2022. The table below presents the year-by-year Long-term Investment Intensity for Gain Therapeutics Inc from 2022 to 2022, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Gain Therapeutics Inc balance sheet assets.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2022 | 8.1% | $1.94 Million | $24.10 Million | — |